3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
5
Phase 3
2
Phase 2
1
Status
Completed
2
Sponsor Class
OTHER
1
NETWORK
1
Study Type
Interventional
2
Sponsor
Cancer Type
Sarcoma
2
Conditions
Leukemia, Myeloid, Acute
19
Leukemia
16
Myelodysplastic Syndromes
11
Precursor Cell Lymphoblastic Leukemia-Lymphoma
5
Neuroblastoma
4
Leukemia, Myeloid, Chronic-Phase
4
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
4
Multiple Myeloma
3
Lymphoma, Large B-Cell, Diffuse
3
Leukemia, Myelomonocytic, Acute
3
Leukemia, Monocytic, Acute
3
Leukemia, Megakaryoblastic, Acute
3
Leukemia, Erythroblastic, Acute
3
Congenital Abnormalities
3
Sarcoma, Ewing
2
Neoplasms, Plasma Cell
2
Myeloproliferative Disorders
2
Lymphoma, Non-Hodgkin
2
Lymphoma, Mantle-Cell
2
Lymphoma, Large-Cell, Immunoblastic
2
Lymphoma, Follicular
2
Lymphoma, B-Cell, Marginal Zone
2
Lymphoma
2
Leukemia, Myelomonocytic, Chronic
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Graft vs Host Disease
2
Burkitt Lymphoma
2
Anemia, Refractory, with Excess of Blasts
2
Sarcoma
1
Recurrence
1
Interventions
Vincristine
2
Ifosfamide
2
Etoposide
2
Doxorubicin
2
Cyclophosphamide
2
Busulfan
2
treosulfan
1
ganitumab
1
etoposide phosphate
1
Zoledronic Acid
1
Triptorelin Pamoate
1
Temozolomide
1
Radiosurgery
1
Radiation
1
Melphalan
1
Irinotecan
1
FANG vaccine
1
Diphosphonates
1
Dactinomycin
1
Cyproheptadine
1
Congresses as Topic
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 3
×
Sarcoma, Ewing
×
Busulfan
×
Clear all
NCT02063022
2022-09-19
EW-1
Italian Sarcoma Group
Phase 3
Completed
278 enrolled
NCT00987636
2019-10-22
EWING2008
University Hospital Muenster
Phase 3
Completed
907 enrolled